Orthofix Medical
OFIX
149 hedge funds and large institutions have $577M invested in Orthofix Medical in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 52 increasing their positions, 41 reducing their positions, and 24 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 41
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
7% more capital invested
Capital invested by funds: $542M → $577M (+$35.4M)
4% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 24
0% more funds holding
Funds holding: 149 → 149 (0)
0% more call options, than puts
Call options by funds: $7K | Put options by funds: $7K
4.33% less ownership
Funds ownership: 90.82% → 86.49% (-4.3%)
Top Buyers
| 1 |
JIC
Juniper Investment Company
New York
|
+$18.6M |
| 2 |
JP Morgan Chase
New York
|
+$3.58M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.77M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$2.29M |
| 5 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
+$2.2M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$13.6M |
| 2 |
AC
Armistice Capital
New York
|
-$13.4M |
| 3 |
NM
Newtyn Management
New York
|
-$12.7M |
| 4 |
TC
Tejara Capital
London,
United Kingdom
|
-$5.88M |
| 5 |
KLP
Kent Lake PR
Anasco,
Puerto Rico
|
-$4.69M |
OFIX Hedge Fund Activity: Q4 2024 in Review
149 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q4 2024, worth a combined $577M — up 6.5% from $542M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new OFIX positions and 24 closed out — a net gain of 1 holder — while 52 added to existing stakes and 41 trimmed.
The largest buyer was Juniper Investment Company, adding an estimated $18.6M. The largest seller was Morgan Stanley, cutting an estimated $13.6M.
- 149 institutional investors held Orthofix Medical (OFIX) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $577M of Orthofix Medical stock for Q4 2024, up 6.5% quarter-over-quarter.
- 25 funds opened new Orthofix Medical positions in Q4 2024 and 24 closed out, a net change of +1 holder.
- The largest Orthofix Medical buyer in Q4 2024 was Juniper Investment Company, an estimated $18.6M added.
- The largest Orthofix Medical seller in Q4 2024 was Morgan Stanley, an estimated $13.6M sold.
Based on aggregated 13F filings for Q4 2024.